Literature DB >> 23851284

Engineering nucleases for gene targeting: safety and regulatory considerations.

Katia Pauwels1, Nancy Podevin, Didier Breyer, Dana Carroll, Philippe Herman.   

Abstract

Nuclease-based gene targeting (NBGT) represents a significant breakthrough in targeted genome editing since it is applicable from single-celled protozoa to human, including several species of economic importance. Along with the fast progress in NBGT and the increasing availability of customized nucleases, more data are available about off-target effects associated with the use of this approach. We discuss how NBGT may offer a new perspective for genetic modification, we address some aspects crucial for a safety improvement of the corresponding techniques and we also briefly relate the use of NBGT applications and products to the regulatory oversight.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23851284     DOI: 10.1016/j.nbt.2013.07.001

Source DB:  PubMed          Journal:  N Biotechnol        ISSN: 1871-6784            Impact factor:   5.079


  29 in total

1.  Modeling the Manipulation of Natural Populations by the Mutagenic Chain Reaction.

Authors:  Robert L Unckless; Philipp W Messer; Tim Connallon; Andrew G Clark
Journal:  Genetics       Date:  2015-07-30       Impact factor: 4.562

Review 2.  Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS.

Authors:  Manjunath N Swamy; Haoquan Wu; Premlata Shankar
Journal:  Adv Drug Deliv Rev       Date:  2016-03-21       Impact factor: 15.470

3.  I-SceI and customized meganucleases-mediated genome editing in tomato and oilseed rape.

Authors:  Benoit Danilo; Émilie Montes; Héloïse Archambeau; Maryse Lodé; Mathieu Rousseau-Gueutin; Anne-Marie Chèvre; Marianne Mazier
Journal:  Transgenic Res       Date:  2021-10-11       Impact factor: 2.788

4.  The Structural Basis of Asymmetry in DNA Binding and Cleavage as Exhibited by the I-SmaMI LAGLIDADG Meganuclease.

Authors:  Betty W Shen; Abigail Lambert; Bradley C Walker; Barry L Stoddard; Brett K Kaiser
Journal:  J Mol Biol       Date:  2015-12-15       Impact factor: 5.469

5.  Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection.

Authors:  Chuka A Didigu; Craig B Wilen; Jianbin Wang; Jennifer Duong; Anthony J Secreto; Gwenn A Danet-Desnoyers; James L Riley; Phillip D Gregory; Carl H June; Michael C Holmes; Robert W Doms
Journal:  Blood       Date:  2013-10-25       Impact factor: 22.113

6.  A Defect in DNA Ligase4 Enhances the Frequency of TALEN-Mediated Targeted Mutagenesis in Rice.

Authors:  Ayako Nishizawa-Yokoi; Tomas Cermak; Tomoki Hoshino; Kazuhiko Sugimoto; Hiroaki Saika; Akiko Mori; Keishi Osakabe; Masao Hamada; Yuichi Katayose; Colby Starker; Daniel F Voytas; Seiichi Toki
Journal:  Plant Physiol       Date:  2015-12-14       Impact factor: 8.340

Review 7.  Genome engineering: Drosophila melanogaster and beyond.

Authors:  Koen J T Venken; Alejandro Sarrion-Perdigones; Paul J Vandeventer; Nicholas S Abel; Audrey E Christiansen; Kristi L Hoffman
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-10-08       Impact factor: 5.814

8.  Disruption of microRNA-21 by TALEN leads to diminished cell transformation and increased expression of cell-environment interaction genes.

Authors:  Buyuan Chen; Xinji Chen; Xiwei Wu; Xiaoling Wang; Yingjia Wang; Ting-Yu Lin; Jessica Kurata; Jun Wu; Steven Vonderfecht; Guihua Sun; He Huang; Jiing-Kuan Yee; Jianda Hu; Ren-Jang Lin
Journal:  Cancer Lett       Date:  2014-10-07       Impact factor: 8.679

9.  Bacterial magnetic particles improve testes-mediated transgene efficiency in mice.

Authors:  Chao Wang; Guanghong Sun; Ye Wang; Nana Kong; Yafei Chi; Leilei Yang; Qiliang Xin; Zhen Teng; Xu Wang; Yujun Wen; Ying Li; Guoliang Xia
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 10.  Applications of Engineered DNA-Binding Molecules Such as TAL Proteins and the CRISPR/Cas System in Biology Research.

Authors:  Toshitsugu Fujita; Hodaka Fujii
Journal:  Int J Mol Sci       Date:  2015-09-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.